105 related articles for article (PubMed ID: 10344471)
1. The effect of erdosteine and its active metabolite on reactive oxygen species production by inflammatory cells.
Miyake K; Kaise T; Hosoe H; Akuta K; Manabe H; Ohmori K
Inflamm Res; 1999 Apr; 48(4):205-9. PubMed ID: 10344471
[TBL] [Abstract][Full Text] [Related]
2. Effects on the reactive oxygen species of erdosteine and its metabolite in vitro.
Hosoe H; Kaise T; Ohmori K
Arzneimittelforschung; 2002; 52(6):435-40. PubMed ID: 12109043
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of metabolite I of erdosteine on the generation of nitric oxide and peroxynitrite chemiluminescence by human neutrophils.
Dal Sasso M; Culici M; Bianchi T; Fonti E; Braga PC
Pharmacology; 2004 Jul; 71(3):120-7. PubMed ID: 15161993
[TBL] [Abstract][Full Text] [Related]
4. The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophils.
Dal Sasso M; Bovio C; Culici M; Fonti E; Braga PC
Drugs Exp Clin Res; 2002; 28(4):147-54. PubMed ID: 12512232
[TBL] [Abstract][Full Text] [Related]
5. Effect of ambroxol on oxygen radical production and generation by bronchoalveolar lavage cells in young and aged guinea pigs.
Teramoto S; Suzuki M; Matsuse T; Ouchi Y
Jpn J Pharmacol; 1998 Dec; 78(4):429-34. PubMed ID: 9920199
[TBL] [Abstract][Full Text] [Related]
6. Mucolytic and antitussive effects of erdosteine.
Hosoe H; Kaise T; Ohmori K; Isohama Y; Kai H; Takahama K; Miyata T
J Pharm Pharmacol; 1999 Aug; 51(8):959-66. PubMed ID: 10504037
[TBL] [Abstract][Full Text] [Related]
7. Erdosteine enhances mucociliary clearance in rats with and without airway inflammation.
Hosoe H; Kaise T; Ohmori K
J Pharmacol Toxicol Methods; 1998 Oct; 40(3):165-71. PubMed ID: 10334633
[TBL] [Abstract][Full Text] [Related]
8. A combination of budesonide and the SH-metabolite I of erdosteine acts synergistically in reducing chemiluminescence during human neutrophil respiratory burst.
Dal Sasso M; Culici M; Guffanti EE; Bianchi T; Fonti E; Braga PC
Pharmacology; 2005 Jun; 74(3):127-34. PubMed ID: 15753624
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine effect on the luminol-dependent chemiluminescence pattern of reactive oxygen species generation by human polymorphonuclear leukocytes.
Stolarek R; Białasiewicz P; Nowak D
Pulm Pharmacol Ther; 2002; 15(4):385-92. PubMed ID: 12220944
[TBL] [Abstract][Full Text] [Related]
10. The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of pulmonary cells.
Demiralay R; Gürsan N; Erdem H
Toxicology; 2006 Feb; 219(1-3):197-207. PubMed ID: 16377052
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of erdosteine against hypochlorous acid-induced acute lung injury and lipopolysaccharide-induced neutrophilic lung inflammation in mice.
Hayashi K; Hosoe H; Kaise T; Ohmori K
J Pharm Pharmacol; 2000 Nov; 52(11):1411-6. PubMed ID: 11186250
[TBL] [Abstract][Full Text] [Related]
12. Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins.
Kim SJ; Park C; Lee JN; Lim H; Hong GY; Moon SK; Lim DJ; Choe SK; Park R
Toxicol Appl Pharmacol; 2015 Oct; 288(2):192-202. PubMed ID: 26193055
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial.
Dal Negro RW; Visconti M; Turco P
Pulm Pharmacol Ther; 2015 Aug; 33():47-51. PubMed ID: 26116425
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the antioxidant activity of the SH metabolite I of erdosteine on human neutrophil oxidative bursts.
Braga PC; Dal Sasso M; Zuccotti T
Arzneimittelforschung; 2000 Aug; 50(8):739-46. PubMed ID: 10994158
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of erdosteine metabolite I against hydrogen peroxide-induced oxidative DNA-damage in lung epithelial cells.
Marabini L; Calò R; Braga PC
Arzneimittelforschung; 2011; 61(12):700-6. PubMed ID: 22282957
[TBL] [Abstract][Full Text] [Related]
16. Regulation of sepsis-induced apoptosis of pulmonary cells by posttreatment of erdosteine and N-aceylcysteine.
Demiralay R; Gürsan N; Erdem H
Toxicology; 2006 Dec; 228(2-3):151-61. PubMed ID: 17046137
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species mediate phorbol ester-stimulated cAMP response in human eosinophils.
Ezeamuzie CI; Taslim N
Eur J Pharmacol; 2006 Aug; 543(1-3):174-80. PubMed ID: 16814765
[TBL] [Abstract][Full Text] [Related]
18. Effect of erdosteine and its metabolites on tracheobronchial mucus production and transport.
Scuri R; Giannetti P; Paesano A
Drugs Exp Clin Res; 1988; 14(11):693-8. PubMed ID: 3246214
[TBL] [Abstract][Full Text] [Related]
19. Depressant effects of ambroxol and erdosteine on cytokine synthesis, granule enzyme release, and free radical production in rat alveolar macrophages activated by lipopolysaccharide.
Jang YY; Song JH; Shin YK; Han ES; Lee CS
Pharmacol Toxicol; 2003 Apr; 92(4):173-9. PubMed ID: 12753420
[TBL] [Abstract][Full Text] [Related]
20. The effect of erdosteine on airway defence mechanisms and inflammatory cytokines in the settings of allergic inflammation.
Fraňová S; Kazimierová I; Pappová L; Molitorisová M; Jošková M; Šutovská M
Pulm Pharmacol Ther; 2019 Feb; 54():60-67. PubMed ID: 30502381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
